Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Galmozzi

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Hepatology|August 27, 2010
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver diseaseLuca Valenti, Elena Canavesi, Enrico Galmozzi, et al.
Journal of Neuroimmunology|May 24, 2006
Increased levels of the CD40:CD40 ligand dyad in the cerebrospinal fluid of rats with vitamin B12(cobalamin)-deficient central neuropathyDaniela Veber, Elena Mutti, Enrico Galmozzi, et al.
Gastroenterology|November 26, 2009
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver diseaseLuca Valenti, Anna Ludovica Fracanzani, Elisabetta Bugianesi, et al.
Biomed Research International|August 13, 2013
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patientsAlessio Aghemo, Elisabetta Degasperi, Maria Grazia Rumi, et al.
Epidemiology and Infection|July 12, 2018
Hepatitis delta virus and hepatocellular carcinoma: an updateRaffaella Romeo, Arnolfo Petruzziello, Eve Isabel Pecheur, et al.
Hepatology (Baltimore, Md.)|August 8, 2020
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAsElisabetta Degasperi, Enrico Galmozzi, Serena Pelusi, et al.
Viral Immunology|July 12, 2021
The CCR5 and CXCR3 Pathways in Hepatitis C Virus Liver Transplanted Recipients Treated by a Direct Antiviral Agent Regimen: Informative Kinetics ProfilesGiuseppe Colucci, Federica Invernizzi, Sara Uceda Renteria, et al.
International Journal of Molecular Sciences|April 30, 2014
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependentRoberta D'Ambrosio, Alessio Aghemo, Raffaele De Francesco, et al.
Hepatology (Baltimore, Md.)|February 15, 2011
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis CLuca Valenti, Mariagrazia Rumi, Enrico Galmozzi, et al.
Journal of Hepatology|January 4, 2017
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis BFanny Lebossé, Barbara Testoni, Judith Fresquet, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Hepatology|August 27, 2010
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver diseaseLuca Valenti, Elena Canavesi, Enrico Galmozzi, et al.
Journal of Neuroimmunology|May 24, 2006
Increased levels of the CD40:CD40 ligand dyad in the cerebrospinal fluid of rats with vitamin B12(cobalamin)-deficient central neuropathyDaniela Veber, Elena Mutti, Enrico Galmozzi, et al.
Gastroenterology|November 26, 2009
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver diseaseLuca Valenti, Anna Ludovica Fracanzani, Elisabetta Bugianesi, et al.
Biomed Research International|August 13, 2013
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patientsAlessio Aghemo, Elisabetta Degasperi, Maria Grazia Rumi, et al.
Epidemiology and Infection|July 12, 2018
Hepatitis delta virus and hepatocellular carcinoma: an updateRaffaella Romeo, Arnolfo Petruzziello, Eve Isabel Pecheur, et al.
Hepatology (Baltimore, Md.)|August 8, 2020
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAsElisabetta Degasperi, Enrico Galmozzi, Serena Pelusi, et al.
Viral Immunology|July 12, 2021
The CCR5 and CXCR3 Pathways in Hepatitis C Virus Liver Transplanted Recipients Treated by a Direct Antiviral Agent Regimen: Informative Kinetics ProfilesGiuseppe Colucci, Federica Invernizzi, Sara Uceda Renteria, et al.
International Journal of Molecular Sciences|April 30, 2014
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependentRoberta D'Ambrosio, Alessio Aghemo, Raffaele De Francesco, et al.
Hepatology (Baltimore, Md.)|February 15, 2011
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis CLuca Valenti, Mariagrazia Rumi, Enrico Galmozzi, et al.
Journal of Hepatology|January 4, 2017
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis BFanny Lebossé, Barbara Testoni, Judith Fresquet, et al.
Pageof 4